Subsidiary Formed in Response to Market Success, Ongoing Expansion Leipzig Site Launches Fixed RPP Model with Contract Commitment

EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in

EDAP TMS S.A. to Participate in International Urology Conferences LYON, France -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, today announces it is actively participating in the Societe Internationale d'Urologie (SIU)

Distributor Meeting, User Group Sessions, Media Conferences to Highlight Ablatherm-HIFU

EDAP TMS S.A. to Present at Roth Capital Conference in New York Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York

EDAP TMS S.A. to Present at the Roth Capital 2007 Orange County Conference Lyon, France, February 16, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and

EDAP TMS S.A. to Release 2006 Second Quarter Financial Results August 8, 2006 Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , will release its second quarter financial results for the period ending June 30, 2006 on Tuesday, August 8, 2006 after the market close.

EDAP TMS S.A. to Release 2006 Year End Financial Results Lyon, France, March 5, 2007 - EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide

EDAP TMS S.A. to Release 2007 First Quarter Results LYON, France , May 7 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution

EDAP TMS S.A. to Release 2007 Second Quarter Results LYON, France , Aug. 16 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and